Farmaceutici Formenti SpA manufactures medicinal and chemical, galenic, and dietetic products. The company is headquartered in Milan, Italy.

Intas is among the top-10 Indian pharmaceutical companies and the largest privately held pharmaceutical company in India, with annual turnover in excess of US$ 1 billion, of which 60% comes from international operations. The group has an extensive geographic footprint with presence in 70 countries worldwide and more than 80% of export revenue coming from US, UK and EU. Intas operates over 10 manufacturing facilities worldwide. These facilities have regulatory approvals from multiple global agencies and enjoy an excellent reputation for quality and compliance. The group has capabilities to produce a wide variety of dosage forms including solid orals, liquids, lyophilized sterile preparations, creams, drops and injectables. Intas employs 12,000 people globally with over 400 located in Europe. The company employs over 800 scientists; spends approximately 6% of sales on R&D per annum and has been granted 27 international patents. In addition to generics formulation, R&D is focused on value added products such as biosimilars, value added and improved generics using novel drug delivery systems (NDDS) and innovative active pharmaceutical ingredients (API). Intas has the largest commercialised portfolio of biosimilars in India and is the first Indian pharmaceutical company to launch a biosimilar in the EU. Intas is privately held, based in Ahmedabad India, and backed by two leading financial investors, Temasek and ChrysCapital

IntraBio Ltd. is a British private company located in Begbroke. The firm manufactures drugs for genetic and neurodegenerative diseases.\nThe company says this about itself: IntraBio Inc. is a biopharmaceutical company with a late-stage drug pipeline including novel treatments for common and rare neurodegenerative diseases. IntraBio's platform results from decades of research and investment at premier universities and institutions worldwide. Its clinical programs leverage the expertise in lysosomal function and intracellular calcium signaling of its scientific founders from the University of Oxford and the University of Munich. IntraBio's management team and consultants have vast commercial experience and a successful track record of drug development in the USA and Europe. Together, IntraBio's team translates innovative scientific research in the fields of lysosomal biology, autophagy, and neurology into novel drugs for a broad spectrum of genetic and neurodegenerative diseases so to significantly improve the lives of patients and their families. IntraBio Inc. is a US corporation with its principal laboratories and offices in Oxford, United Kingdom.

Mor Research Applications is the Technology Transfer Office of Clalit Health Services, the largest HMO in Israel, providing end-to-end technology transfer services. MOR helps inventors translate new ideas in the medical, pharmaceutical, diagnostics, medical IT, and biotechnology areas into products and solutions that benefit healthcare providers and patients.

Hennig Arzneimittel is a company that provides proprietary drugs to the German market and also offers a broad range of generics. HENNIG Arzneimittel offers proprietary drugs to the German market for the indications of vertigo and disturbance of equilibrium, where it is the market leader. HENNIG Arzneimittel also manufactures and offers a broad range of generics, including all generic antivertigo products. They also manufacture products for cardiovascular, metabolic, neurologic, and psychiatric conditions.

Lepu Hengjiuyuan Pharmaceutical Co., Ltd., established on 2002-06-20, Business range includes tablet(Hormone),hard capsule,Granules,API(Vizyme,Norfloxacin Glutamate,Antazoline Hydrochloride,Daidzein)Production,research and development,Sales;Bioengineering technology development,consult,comminicate,transfer,Promotion service;Health food production,R & D and sales;General Cargo Warehousing Services;Engaged in the import and export of goods and technology(Except for goods and technologies that should be subject to approval before being operated or prohibited for import and export according to national laws and regulations)

Ami Lifesciences is a pharmaceutical company that provides medications to those in need. They aspire to be a long-term enterprise that adds value to its stakeholders, employees, clients, and society. Its profit is generated through innovation and science, and its after-profit activities are guided by its conscience. The company creates products that promote people's health while also protecting the environment and keeping its workers and customers safe.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Heilongjiang Yidahong Pharmaceutical Co., Ltd., established on 2021-01-12, The scope of business includes the manufacture of chemical preparations(tablet).

Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA.

Beijing Minkang Baicao Pharmaceutical Technology Co., Ltd., established on 2006-04-18, Business scope includes biological,Chemical,Technology development in the field of medical expertise,technology transfer,technical consulting,Technical Services;commissioned drug production;Sales of chemical products and raw materials(Free of Hazardous Chemicals).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

Disphar International offers generic and value-added pharmaceutical products and development, licensing out of pharmaceutical products.

Xiamen Encheng Pharmaceutical Co., Ltd., established on 2006-12-22, The scope of business includes the manufacture of chemical pharmaceutical raw materials(Free of hazardous chemicals, monitored chemicals and non-pharmaceutical precursor chemicals);Manufacturing of chemical preparations;Import and export of various commodities and technologies(Import and export commodity catalog is not attached),Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of;Medical Research and Experimental Development;Biotechnology Extension Services;Other unlisted professional and technical service industries(Not subject to permit approval).

Lambda Therapeutic Research, Ltd. operates as a contract research organization to deliver clinical development solutions. The company's services include clinical trials implementation, laboratory and data management, information technology support, medical affairs assistance, quality assurance, and bio analysis. In addition, the company conducts pharmacokinetic, bioequivalence, first-in-human, and biostatistics study programs. Lambda Therapeutic Research, Ltd. also provides therapeutic services for dermatology, oncology, rheumatology, cardiovascular, central nervous system, and autoimmune deficiencies. Lambda Therapeutic Research Ltd. was incorporated in 1998 and is based in Ahmedabad, India with additional facilities in Mumbai, India and Erwitte, Germany.